Use of RBM39 as a biomaker
US9556489B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 4, 2013 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Mar 4, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to the use (i) of a level of expression of a long RBM39 protein isoform, termed RBM39L, and (ii) of a level of expression of a short RBM39 protein isoform, termed RBM39C, as a marker for the efficacy of an active agent capable of preventing and/or treating HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.